Penserra Capital Management LLC Medicinova Inc Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.61 - $4.42 $2,923 - $4,950	-1,120 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.4 - $4.24 $34 - $42	10 Added 0.9%	1,120 $4,000
Q2 2021 Aug 12, 2021	BUY	$3.76 - $5.14 $18 - $25	5 Added 0.45%	1,110 $4,000
Q1 2021 May 13, 2021	BUY	$4.81 - $8.74 $360 - $655	75 Added 7.28%	1,105 $5,000
Q4 2020 Feb 12, 2021	BUY	$5.03 - $6.31 $5,180 - $6,499	1,030 New	1,030 $5,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $104M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.